The pathophysiology of COVID-19 involves complex interactions between oxidative stress and inflammation, with viral binding to ACE2 initiating endothelial and mitochondrial dysfunction that exacerbates the production of reactive oxygen species, further promoting a pro-inflammatory state and endothelial damage. The gene discussed is ACE2; the disease is COVID-19.